Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Henry

Showing results (181-190 of 278) with videos related to

Pageof 28
Sort By:
Digestive Diseases (Basel, Switzerland)|May 28, 2025
Projected Tumor Characteristics and Survival of Patients with Nonviral Hepatocellular Carcinoma in the USAJoanne Kimiko Liu, Nicholas Chien, Curtis Chong, et al.
BMJ Open Gastroenterology|April 3, 2018
Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosisSally Ann Tran, An Le, Changqing Zhao, et al.
The Annals of Thoracic Surgery|March 27, 2010
Percutaneous catheter ablation treatment of recurring atrial arrhythmias after surgical ablationLinda Henry, Sarfraz Durrani, Sharon Hunt, et al.
Hepatology (Baltimore, Md.)|January 16, 2022
Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysisHaesuk Park, Wei-Hsuan Lo-Ciganic, James Huang, et al.
Scientific Reports|October 27, 2022
Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infectionHaesuk Park, Wei-Hsuan Lo-Ciganic, James Huang, et al.
Annals of Hepatology|April 23, 2023
Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)James M Paik, Katherine E Eberly, Khaled Kabbara, et al.
Clinics in Liver Disease|May 16, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease: Global Epidemiology, Patient-Reported Outcomes, and Economic ImpactJames M Paik, Linda Henry, Khalid AlNaamani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported OutcomesPatrice Cacoub, Marc Bourliere, Tarik Asselah, et al.
European Journal of Gastroenterology & Hepatology|April 19, 2021
A population-based US study of hepatitis C diagnosis rateYee Hui Yeo, Leslie Y Kam, Michael H Le, et al.
Journal of the National Cancer Institute|July 9, 2025
Association between glucagon-like peptidase 1 receptor agonist and obesity-related cancer in overweight or obese patients with type 2 diabetes: a nationwide cohort studyXianhua Mao, Xinrong Zhang, Linda Henry, et al.
Pageof 28

Showing results (181-190 of 278) with videos related to

Sort By:
Pageof 28
Digestive Diseases (Basel, Switzerland)|May 28, 2025
Projected Tumor Characteristics and Survival of Patients with Nonviral Hepatocellular Carcinoma in the USAJoanne Kimiko Liu, Nicholas Chien, Curtis Chong, et al.
BMJ Open Gastroenterology|April 3, 2018
Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosisSally Ann Tran, An Le, Changqing Zhao, et al.
The Annals of Thoracic Surgery|March 27, 2010
Percutaneous catheter ablation treatment of recurring atrial arrhythmias after surgical ablationLinda Henry, Sarfraz Durrani, Sharon Hunt, et al.
Hepatology (Baltimore, Md.)|January 16, 2022
Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysisHaesuk Park, Wei-Hsuan Lo-Ciganic, James Huang, et al.
Scientific Reports|October 27, 2022
Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infectionHaesuk Park, Wei-Hsuan Lo-Ciganic, James Huang, et al.
Annals of Hepatology|April 23, 2023
Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)James M Paik, Katherine E Eberly, Khaled Kabbara, et al.
Clinics in Liver Disease|May 16, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease: Global Epidemiology, Patient-Reported Outcomes, and Economic ImpactJames M Paik, Linda Henry, Khalid AlNaamani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported OutcomesPatrice Cacoub, Marc Bourliere, Tarik Asselah, et al.
European Journal of Gastroenterology & Hepatology|April 19, 2021
A population-based US study of hepatitis C diagnosis rateYee Hui Yeo, Leslie Y Kam, Michael H Le, et al.
Journal of the National Cancer Institute|July 9, 2025
Association between glucagon-like peptidase 1 receptor agonist and obesity-related cancer in overweight or obese patients with type 2 diabetes: a nationwide cohort studyXianhua Mao, Xinrong Zhang, Linda Henry, et al.
Pageof 28